Literature DB >> 7034252

Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases.

I A Jaffe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7034252     DOI： 10.1007/bf01857095

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  86 in total

1.  Immune deficiencies, aplastic anemia and abnormalities of lymphoid tissue in thymoma.

Authors:  D Korn; A Gelderman; G Cage; D Nathanson; A J Strauss
Journal:  N Engl J Med       Date:  1967-06-15       Impact factor: 91.245

2.  Failure of oral D-penicillamine to modify adjuvant arthritis or immune response in the rat.

Authors:  S P Liyanage; H L Currey
Journal:  Ann Rheum Dis       Date:  1972-11       Impact factor: 19.103

3.  [Pemphigus in a patient treated with penicillamine for Wilson's disease].

Authors:  R Degos; R Touraine; S Belaïch; J Revuz
Journal:  Bull Soc Fr Dermatol Syphiligr       Date:  1969

4.  Toxic reactions to penicillamine in patients with Wilson's disease.

Authors:  J M Walshe
Journal:  Postgrad Med J       Date:  1968-10       Impact factor: 2.401

5.  [Nephrotic syndrome related to the use of pyrithioxin in the treatment of rheumatoid arthritis].

Authors:  B Amor; A Cherot; F Delbarre
Journal:  Nouv Presse Med       Date:  1979-06-02

6.  Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia.

Authors:  R Hoffman; E D Zanjani; J D Lutton; R Zalusky; L R Wasserman
Journal:  N Engl J Med       Date:  1977-01-06       Impact factor: 91.245

7.  5-Thiopyridoxine in rheumatoid arthritis: clinical and experimental studies.

Authors:  E C Huskisson; I A Jaffe; J Scott; P A Dieppe
Journal:  Arthritis Rheum       Date:  1980-01

8.  Methyldopa inhibition of suppressor-lymphocyte function: a proposed cause of autoimmune hemolytic anemia.

Authors:  H H Kirtland; D N Mohler; D A Horwitz
Journal:  N Engl J Med       Date:  1980-04-10       Impact factor: 91.245

9.  Penicillamine-associated pemphigus: is it really pemphigus?

Authors:  J L Troy; D N Silvers; M E Grossman; I A Jaffe
Journal:  J Am Acad Dermatol       Date:  1981-05       Impact factor: 11.527

10.  Penicillamine-induced polymyositis-dermatomyositis.

Authors:  J Petersen; P Halberg; K Højgaard; B B Lyon; S Ullman
Journal:  Scand J Rheumatol       Date:  1978       Impact factor: 3.641
View more
  8 in total

1.  Kinetics and pathogenicity of autoantibodies induced by mercuric chloride in the brown Norway rat.

Authors:  C D Pusey; C Bowman; A Morgan; A P Weetman; B Hartley; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

2.  Concomitant immune-related events in Wilson disease: implications for monitoring chelator therapy.

Authors:  Jessica Seessle; Daniel Nils Gotthardt; Mark Schäfer; Annina Gohdes; Jan Pfeiffenberger; Peter Ferenci; Wolfgang Stremmel; Karl Heinz Weiss
Journal:  J Inherit Metab Dis       Date:  2015-06-12       Impact factor: 4.982

Review 3.  Tendinopathy.

Authors:  Neal L Millar; Karin G Silbernagel; Kristian Thorborg; Paul D Kirwan; Leesa M Galatz; Geoffrey D Abrams; George A C Murrell; Iain B McInnes; Scott A Rodeo
Journal:  Nat Rev Dis Primers       Date:  2021-01-07       Impact factor: 52.329

4.  How adverse drug reactions can play a role in innovative drug research.

Authors:  F Rikken; R Vos
Journal:  Pharm World Sci       Date:  1995-11-24

Review 5.  Role of animal models in the study of drug-induced hypersensitivity reactions.

Authors:  Jack Uetrecht
Journal:  AAPS J       Date:  2006-01-13       Impact factor: 4.009

Review 6.  Disease-modifying antirheumatic drugs. Using their clinical pharmacological effects as a guide to their selection.

Authors:  C G Jackson; H J Williams
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546

7.  The induction of human antinuclear antibodies by D-penicillamine: activation of inducer helper T cells in the absence of irradiation sensitive suppressor T cells.

Authors:  P S Mach; H Brouilhet; B Amor
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

Review 8.  D-Penicillamine: The State of the Art in Humans and in Dogs from a Pharmacological and Regulatory Perspective.

Authors:  Michela Pugliese; Vito Biondi; Enrico Gugliandolo; Patrizia Licata; Alessio Filippo Peritore; Rosalia Crupi; Annamaria Passantino
Journal:  Antibiotics (Basel)       Date:  2021-05-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.